Shurin M R, Pandharipande P P, Zorina T D, Haluszczak C, Subbotin V M, Hunter O, Brumfield A, Storkus W J, Maraskovsky E, Lotze M T
Biologic Therapeutics Program, University of Pittsburgh Cancer Institute, Pennsylvania 15213, USA.
Cell Immunol. 1997 Aug 1;179(2):174-84. doi: 10.1006/cimm.1997.1152.
FLT3 ligand (FL) is a recently described hematopoietic growth factor that stimulates the proliferation and differentiation of hematopoietic progenitors. We have investigated the effect of FL on murine hematopoiesis and dendritic cell (DC) generation and accumulation in lymphoid tissues and liver in vivo and in vitro evaluating the morphologic, phenotypic, and functional characteristics of these DC. We have observed extramedullary hematopoiesis in the mouse spleen with all lineages of hematopoietic cells represented after the administration of FL. Injection of FL results in a time-dependent and reversible accumulation of DC in the spleen, bone marrow, lymph nodes, and liver. Both flow cytometry and immunohistochemistry revealed a significant accumulation of DC in these tissues. Results of mixed leukocyte reaction suggested that these cells, isolated from murine bone marrow or spleen, were active as antigen presenting cells. Furthermore, cultivation of splenic and marrow cells with GM-CSF and IL-4 gave rise to large numbers of functionally active mature DC. Thus, the results of this study suggest that FL is a promising growth factor that stimulates the generation of large number of DC and may be a useful cytokine for the immunotherapy of cancer.
Flt3配体(FL)是一种最近被描述的造血生长因子,可刺激造血祖细胞的增殖和分化。我们研究了FL对小鼠造血以及体内外淋巴组织和肝脏中树突状细胞(DC)生成和积聚的影响,并评估了这些DC的形态、表型和功能特征。我们观察到,给予FL后,小鼠脾脏出现髓外造血,所有造血细胞谱系均有代表。注射FL导致DC在脾脏、骨髓、淋巴结和肝脏中呈时间依赖性且可逆的积聚。流式细胞术和免疫组织化学结果均显示这些组织中DC显著积聚。混合淋巴细胞反应结果表明,从鼠骨髓或脾脏分离出的这些细胞作为抗原呈递细胞具有活性。此外,用GM-CSF和IL-4培养脾细胞和骨髓细胞可产生大量功能活跃的成熟DC。因此,本研究结果表明,FL是一种有前景的生长因子,可刺激大量DC的生成,可能是一种用于癌症免疫治疗的有用细胞因子。